Cargando…

Iguratimod Restrains Circulating Follicular Helper T Cell Function by Inhibiting Glucose Metabolism via Hif1α-HK2 Axis in Rheumatoid Arthritis

Iguratimod (IGU) is a novel disease modified anti-rheumatic drug, which has been found to act directly on B cells for inhibiting the production of antibodies in rheumatoid arthritis (RA) patients. Follicular helper T (Tfh) cells, a key T cell subsets in supporting B cell differentiation and antibody...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Ziran, Lu, Zhimin, Liu, Rui, Tang, Yawei, Ye, Xiaokang, Jin, Minli, Wang, Guan, Li, Xia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199372/ https://www.ncbi.nlm.nih.gov/pubmed/35720293 http://dx.doi.org/10.3389/fimmu.2022.757616

Ejemplares similares

Efficacy and Safety of Iguratimod for the Treatment of Rheumatoid Arthritis
por: Li, Jiangtao, et al.
Publicado: (2013)

Increased Frequency of Circulating Follicular Helper T Cells in Patients with Rheumatoid Arthritis
por: Ma, Jie, et al.
Publicado: (2012)

Altered Distribution of Circulating T Follicular Helper-Like Cell Subsets in Rheumatoid Arthritis Patients
por: Su, Rui, et al.
Publicado: (2021)

Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape
por: Xie, Sisi, et al.
Publicado: (2020)

T follicular helper cells and T follicular regulatory cells in autoimmune diseases
por: Qi, Jingjing, et al.
Publicado: (2023)

Corrigendum: Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape
por: Xie, Sisi, et al.
Publicado: (2020)

Iguratimod Inhibits the Aggressiveness of Rheumatoid Fibroblast-Like Synoviocytes
por: Lin, Jin, et al.
Publicado: (2019)

The transcription factor KLF2 restrains CD4(+) T follicular helper cell differentiation
por: Lee, June-Yong, et al.
Publicado: (2015)

Dynamics of circulating follicular helper T cell subsets and follicular regulatory T cells in rheumatoid arthritis patients according to HLA-DRB1 locus
por: Ferrero, Paola V., et al.
Publicado: (2022)

Influence of Iguratimod on Bone Metabolism in Patients with Rheumatoid Arthritis: A Meta-analysis
por: Deng, Li, et al.
Publicado: (2022)

Regulatory T cells require the phosphatase PTEN to restrain type 1 and follicular helper T-cell responses
por: Shrestha, Sharad, et al.
Publicado: (2015)

Enhanced IL-6/phosphorylated STAT3 signaling is related to the imbalance of circulating T follicular helper/T follicular regulatory cells in patients with rheumatoid arthritis
por: Niu, Qian, et al.
Publicado: (2018)

Conflict between efficacy and economy in rheumatoid arthritis treatment: Iguratimod is found at a compromise
por: Tanaka, Masao
Publicado: (2021)

The Phenotype of Circulating Follicular-Helper T Cells in Patients with Rheumatoid Arthritis Defines CD200 as a Potential Therapeutic Target
por: Chakera, Aron, et al.
Publicado: (2012)

The circulating life of a memory T-follicular helper cell
por: Ma, Cindy S, et al.
Publicado: (2017)

The circulating life of a memory T-follicular helper cell
por: Ma, Cindy S, et al.
Publicado: (2017)

The link between circulating follicular helper T cells and autoimmunity
por: Walker, Lucy S. K.
Publicado: (2022)

Regulatory Effect of Iguratimod on the Balance of Th Subsets and Inhibition of Inflammatory Cytokines in Patients with Rheumatoid Arthritis
por: Xu, Yunzhi, et al.
Publicado: (2015)

HIF1α-Dependent Metabolic Signals Control the Differentiation of Follicular Helper T Cells
por: Dong, Lin, et al.
Publicado: (2019)

Functional subsets of circulating follicular helper T cells in patients with atherosclerosis
por: Ghamar Talepoor, Atefe, et al.
Publicado: (2020)

Allogeneic mesenchymal stem cells inhibited T follicular helper cell generation in rheumatoid arthritis
por: Liu, Rui, et al.
Publicado: (2015)

The Effectiveness and Retention Rate of Iguratimod in Japanese Rheumatoid Arthritis Patients with/without Methotrexate in Daily Medical Care
por: Inoue, Asuka, et al.
Publicado: (2020)

Iguratimod: Novel Molecular Insights and a New csDMARD for Rheumatoid Arthritis, from Japan to the World
por: Nozaki, Yuji
Publicado: (2021)

Preparation of a Major Metabolite of Iguratimod and Simultaneous Assay of Iguratimod and Its Metabolite by HPLC in Rat Plasma
por: Han, Jun-ping, et al.
Publicado: (2019)

Altered circulating T follicular helper cells in patients with chronic immune thrombocytopenia
por: Dai, Lan, et al.
Publicado: (2018)

Distribution of distinct subsets of circulating T follicular helper cells in Kawasaki disease
por: Xu, Meng, et al.
Publicado: (2019)

Association of Platelet Desialylation and Circulating Follicular Helper T Cells in Patients With Thrombocytopenia
por: Chen, Yuwen, et al.
Publicado: (2022)

Clonal composition and persistence of antigen‐specific circulating T follicular helper cells
por: Hu, Mengyun, et al.
Publicado: (2022)

Iguratimod efficacy in palindromic rheumatism treatment
por: Yuan, Fangfang, et al.
Publicado: (2023)

Iguratimod promotes transformation of mononuclear macrophages in elderly patients with rheumatoid arthritis by nuclear factor-κB pathway
por: Liu, Sha, et al.
Publicado: (2021)

Clinical Efficacy of Methotrexate Combined with Iguratimod on Patients with Rheumatoid Arthritis and Its Influence on the Expression Levels of HOTAIR in Serum
por: Tan, Jingya, et al.
Publicado: (2021)

Effectiveness of iguratimod as monotherapy or combined therapy in patients with rheumatoid arthritis: a systematic review and meta-analysis of RCTs
por: Hu, Chao-Jun, et al.
Publicado: (2021)

Effectiveness and Safety of Iguratimod Monotherapy or Combined With Methotrexate in Treating Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Ouyang, Dan, et al.
Publicado: (2022)

A prospective observational cohort study of the efficacy of tofacitinib plus iguratimod on rheumatoid arthritis with usual interstitial pneumonia
por: Wang, Shuhua, et al.
Publicado: (2023)

Altered ratio of circulating follicular regulatory T cells and follicular helper T cells during primary EBV infection
por: Qian, Jiang, et al.
Publicado: (2020)

Reconstitution of T follicular helper-humoral immune axis with elimination of hepatitis C virus
por: Khanam, Arshi, et al.
Publicado: (2020)

Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis
por: Ye, Yan, et al.
Publicado: (2019)

A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis
por: Liu, Rui, et al.
Publicado: (2012)

Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis
por: Tokai, Nao, et al.
Publicado: (2018)

Effectiveness and safety of iguratimod treatment in patients with active rheumatoid arthritis in Chinese: A nationwide, prospective real-world study
por: Mu, Rong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a285kgs00v8ntgogu0qt58lhfd